These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1292 related articles for article (PubMed ID: 12508386)

  • 1. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1 beta, and IL-8--markers of remission in rheumatoid arthritis during treatment with methotrexate.
    Seitz M; Loetscher P; Dewald B; Towbin H; Rordorf C; Gallati H; Gerber NJ
    J Rheumatol; 1996 Sep; 23(9):1512-6. PubMed ID: 8877917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of methotrexate on differentiation of monocytes and production of cytokine inhibitors by monocytes.
    Seitz M; Zwicker M; Loetscher P
    Arthritis Rheum; 1998 Nov; 41(11):2032-8. PubMed ID: 9811059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced in vitro induced production of interleukin 10 by peripheral blood mononuclear cells in rheumatoid arthritis is associated with clinical response to methotrexate treatment.
    Seitz M; Zwicker M; Wider B
    J Rheumatol; 2001 Mar; 28(3):496-501. PubMed ID: 11296948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel predictor of clinical response to methotrexate in patients with rheumatoid arthritis: a pilot study of in vitro T cell cytokine suppression.
    Haroon N; Srivastava R; Misra R; Aggarwal A
    J Rheumatol; 2008 Jun; 35(6):975-8. PubMed ID: 18464312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment with etanercept significantly reduces the number of proinflammatory cytokine-secreting peripheral blood mononuclear cells in patients with rheumatoid arthritis.
    Schotte H; Schlüter B; Willeke P; Mickholz E; Schorat MA; Domschke W; Gaubitz M
    Rheumatology (Oxford); 2004 Aug; 43(8):960-4. PubMed ID: 15026584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro modulation of cytokine, cytokine inhibitor, and prostaglandin E release from blood mononuclear cells and synovial fibroblasts by antirheumatic drugs.
    Seitz M; Loetscher P; Dewald B; Towbin H; Baggiolini M
    J Rheumatol; 1997 Aug; 24(8):1471-6. PubMed ID: 9263137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1beta influences the effect of infliximab on temporomandibular joint pain in rheumatoid arthritis.
    Kopp S; Alstergren P; Ernestam S; Nordahl S; Bratt J
    Scand J Rheumatol; 2006; 35(3):182-8. PubMed ID: 16766364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.
    Muzaffer MA; Dayer JM; Feldman BM; Pruzanski W; Roux-Lombard P; Schneider R; Laxer RM; Silverman ED
    J Rheumatol; 2002 May; 29(5):1071-8. PubMed ID: 12022325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
    Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
    J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor blockade differentially affects innate inflammatory and Th17 cytokines in rheumatoid arthritis.
    Zivojinovic SM; Pejnovic NN; Sefik-Bukilica MN; Kovacevic LV; Soldatovic II; Damjanov NS
    J Rheumatol; 2012 Jan; 39(1):18-21. PubMed ID: 22133625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-alpha and soluble tumor necrosis factor receptors in the culture supernatants of polymorphonuclear cells and peripheral blood mononuclear cells from cancer patients.
    Jablońska E; Kiluk M; Piotrowski L; Grabowska Z; Markiewicz W; Jablonski J
    Eur Cytokine Netw; 1998 Jun; 9(2):155-9. PubMed ID: 9681391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment.
    Ziolkowska M; Kurowska M; Radzikowska A; Luszczykiewicz G; Wiland P; Dziewczopolski W; Filipowicz-Sosnowska A; Pazdur J; Szechinski J; Kowalczewski J; Rell-Bakalarska M; Maslinski W
    Arthritis Rheum; 2002 Jul; 46(7):1744-53. PubMed ID: 12124857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative and antiinflammatory effects of methotrexate on cultured differentiating myeloid monocytic cells (THP-1) but not on synovial macrophages from patients with rheumatoid arthritis.
    Cutolo M; Bisso A; Sulli A; Felli L; Briata M; Pizzorni C; Villaggio B
    J Rheumatol; 2000 Nov; 27(11):2551-7. PubMed ID: 11093433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
    Mathsson L; Lampa J; Mullazehi M; Rönnelid J
    Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive periodontitis and chronic arthritis: blood mononuclear cell gene expression and plasma protein levels of cytokines and cytokine inhibitors.
    Sørensen LK; Havemose-Poulsen A; Bendtzen K; Holmstrup P
    J Periodontol; 2009 Feb; 80(2):282-9. PubMed ID: 19186969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass.
    Gormley SM; McBride WT; Armstrong MA; McClean E; MacGowan SW; Campalani G; McMurray TJ
    Cytokine; 2002 Jan; 17(2):61-5. PubMed ID: 11886172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in biomarkers of inflammation and bone turnover and associations with clinical efficacy following infliximab plus methotrexate therapy in patients with early rheumatoid arthritis.
    Visvanathan S; Marini JC; Smolen JS; Clair EW; Pritchard C; Shergy W; Pendley C; Baker D; Bala M; Gathany T; Han J; Wagner C
    J Rheumatol; 2007 Jul; 34(7):1465-74. PubMed ID: 17552048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T; Gladalska A; Stepień H
    Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph draining from foot joints in rheumatoid arthritis provides insight into local cytokine and chemokine production and transport to lymph nodes.
    Olszewski WL; Pazdur J; Kubasiewicz E; Zaleska M; Cooke CJ; Miller NE
    Arthritis Rheum; 2001 Mar; 44(3):541-9. PubMed ID: 11263768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.